RLAY peer analysis
Relay Therapeutics (RLAY) against its competitors: price, today's move, 1-year return and market value side by side.
RLAY and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| AVBP ArriVent BioPharma | $13.52 | 10.58% | -26.22% | – |
| ERAS Erasca | $14.57 | 9.80% | 562.27% | – |
| IDYA IDEAYA Biosciences | $31.24 | 1.92% | 5.33% | $2.74B |
| KYMR Kymera Therapeutics | $131.07 | 2.30% | 118.85% | – |
| NRIX Nurix Therapeutics | $15.07 | 1.55% | 21.00% | – |
| ORIC Oric | $8.82 | 3.89% | -28.76% | $914.22M |
| PRLD Prelude Therapeutics | $3.60 | 1.27% | 158.99% | – |
| RVMD Revolution Medicines | $194.38 | 9.41% | 227.56% | $41.66B |
| TNGX Tango Therapeutics | $21.50 | 3.02% | 186.28% | – |
| TYRA Tyra Biosciences | $21.15 | 1.24% | 42.71% | – |
| RLAY Relay Therapeutics | $18.88 | 11.06% | 188.24% | – |
- RLAY's peers: AVBP (ArriVent BioPharma), ERAS (Erasca), IDYA (IDEAYA Biosciences), KYMR (Kymera Therapeutics), NRIX (Nurix Therapeutics), ORIC (Oric), PRLD (Prelude Therapeutics), RVMD (Revolution Medicines).
Updated 2026-11-07 11:54 UTC